Literature DB >> 2436649

Association of thalassaemia intermedia with a beta-globin gene haplotype.

S L Thein, J S Wainscoat, M Sampietro, J M Old, D Cappellini, G Fiorelli, B Modell, D J Weatherall.   

Abstract

We have identified 14 Asian patients with homozygous beta zero thalassaemia who had a mild clinical disorder related to an augmented production of haemoglobin F. None of their parents had an elevated level of Hb F. Restriction fragment length polymorphism analysis of the beta-globin cluster of these patients and a control group of Asian thalassaemia major patients showed that 6/14 of the thalassaemia intermedia patients were homozygous for a particular 5' beta-globin haplotype (-+-++), in contrast to 1/42 of the thalassaemia major patients. Furthermore, the -+-++ beta haplotype is also associated with amelioration of disease severity in beta thalassaemia in an Italian population. This beta haplotype is linked to a DNA sequence variation 5' (at position -158) to the G gamma globin gene which can be detected by the presence (+) of an Xmn I restriction enzyme site. The possible role of the Xmn I-gamma polymorphism in relation to this variant HPFH is discussed. We conclude that much of the observed clinical variability of beta thalassaemia can now be explained by the inheritance of beta thalassaemia chromosomes with different propensities for fetal haemoglobin production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436649     DOI: 10.1111/j.1365-2141.1987.tb06870.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

1.  Evidence of genetic interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin.

Authors:  Chad P Garner; Thanusak Tatu; Steve Best; Lisa Creary; Swee Lay Thein
Journal:  Am J Hum Genet       Date:  2002-01-30       Impact factor: 11.025

2.  Analysis of beta-globin gene haplotypes in Asian Indians: origin and spread of beta-thalassaemia on the Indian subcontinent.

Authors:  N Y Varawalla; A C Fitches; J M Old
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

3.  Beta-thalassaemia: molecular pathogenesis and clinical variability.

Authors:  A E Kulozik
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

4.  Intrinsic potential for high fetal hemoglobin production in a Druz family with beta-thalassemia is due to an unlinked genetic determinant.

Authors:  A Oppenheim; A Yaari; D Rund; E A Rachmilewitz; D Nathan; C Wong; H H Kazazian; B Miller
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

5.  G gamma and A gamma globin genes are identical from -471 of the promoter midway through gamma IVSII in a Benin beta s haplotype associated with elevated fetal hemoglobin.

Authors:  N Mishima; E C Brinson; P F Milner; J G Gilman
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

Review 6.  Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.

Authors:  Swee Lay Thein; Stephan Menzel; Mark Lathrop; Chad Garner
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

7.  Effect of alpha thalassaemia trait and enhanced gamma chain production on disease severity in beta thalassaemia major and intermedia.

Authors:  P Gringras; B Wonke; J Old; A Fitches; D Valler; A M Kuan; V Hoffbrand
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

Review 8.  Omics Studies in Hemoglobinopathies.

Authors:  Eleni Katsantoni
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

9.  BCL2L1 is associated with γ-globin gene expression.

Authors:  Yan Dai; Elmutaz M Shaikho; Jessica Perez; Carolyn A Wilson; Lesley Y Liu; Mitchell R White; John J Farrell; David H K Chui; Paola Sebastiani; Martin H Steinberg
Journal:  Blood Adv       Date:  2019-10-22

10.  Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China.

Authors:  Rong Rong Liu; Ming Yue Wang; Yong Rong Lai
Journal:  J Hematol Oncol       Date:  2010-09-07       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.